Loading organizations...
The Helvetia Venture Fund provides early-stage capital to companies developing innovations across the insurance, healthcare, and mobility ecosystems. Managed by b2venture (formerly btov Partners), the fund targets startups with technologies and business models strategically relevant to the Helvetia Group, driving novel solutions for these interconnected industries.
Launched in 2020 by Helvetia Insurance, the fund was created to engage with emerging technologies impacting its core business. Its partnership with b2venture, an experienced early-stage VC firm, provides a robust framework and network for identifying and cultivating promising ventures during their pre-seed, seed, and Series A funding rounds.
The fund seeks to integrate cutting-edge solutions into Helvetia's offerings, enhancing its market position. Its vision involves fostering a portfolio of commercially viable companies that align with Helvetia's strategic objectives, thereby driving innovation and shaping the future of insurance and related sectors through targeted early-stage investments.
btov/Helvetia Venture Fund has 1 tracked investment across 1 company. The latest tracked deal is $34.0M Series B in PriceHubble in July 2021.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jul 1, 2021 | PriceHubble | $34.0M Series B | — | Adverb Ventures, Antler, Coelius Capital, Colle Capital, CSC Venture Capital, Dawn Capital, Kevin Ding, DN Capital, FJ Labs, Homebrew, Khosla Ventures, LocalGlobe, MMC Ventures, Nokia Growth Partners, Norwest Venture Partners, Prelude Ventures, Target Global, Andy Rankin, Anshu Sharma, Anthony Soohoo, DON Hutchison, JAN Deepen, Marc Mccabe, Sascha Weiler, Stefan Jeschonnek, Vishal Makhijani, DR. Martin E., Remus Brett, Swiss Life, TX Group, TX Ventures, Venture Fund |